Case Reports
Thought Leadership on Thrombotic Disorders in South East Asia
Mark Y. Chan
21 May 2014
April 2014, 22:4
Case Reports
References
1. http://www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed 6-1-2014).
2. http://www.portola.com/Anticoagulant-Market (accessed 6-1-2014).
3. http://www.nrdo.gov.sg/uploadedFiles/NRDO/Publications/20110211%20AMI%20Information%20Paper%202010%20v3.pdf (accessed 6-1-2014).
4. http://www.moh.gov.sg/content/moh_web/home/costs_and_financing/HospitalBillSize.html (accessed 6-1-2014).
5. Cho Yeow Koh, Maria Kazimirova, Adama Trimnell, Peter Takac, Milan Labuda, Patricia A. Nuttall, and R. Manjunatha Kini: Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick. Journal of Biological Chemistry, 282, 40, 29101–29113.
6. http://www.cardiosource.org/Science-And-Quality/Clinical-Trials/H/HEAT-PPCI.aspx (accessed 17-4-2014)
7. Tan Huay Cheem, Heparin has No Place as an Anticoagulant in PCI – A Protagonist’s View, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 14-18 (2014).
8. Kim Moo Hyun, Opposition: Unfractionated heparin should no longer be used in the catheterization laboratory, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 38-41 (2014).
9. Chee Yen Lin, New Oral Anticoagulants, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 30-37 (2014).
10. Alan Fong, Thrombin and FXa plasma concentration levels in patients with atrial fi brillation on long term warfarin therapy, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 20-29 (2014).
.